Science ❯ Biotechnology

Monoclonal Antibodies

Research Collaboration Protein Modification Alzheimer's Research Amyloid-beta Immune Checkpoint Inhibitors Therapeutic Development Research Methods Immunoassays Testing Methods

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Targeting acetylated tau, the candidate has entered an FDA-cleared first-in-human trial with Sanofi set to lead later development.

Mirum to Acquire Bluejay Therapeutics in Up to $820 Million Deal for Hepatitis D Drug

FDA Issues Draft Guidance Easing Primate Tests for Some Antibody Drugs

EU Regulators Back Libtayo as Adjuvant Therapy for High-Risk Cutaneous Squamous Cell Carcinoma